The study was designed to evaluate the safety and efficacy of GVAX immunotherapy for pancreatic cancer. Patients that were examined had operable pancreatic cancer who received the immunotherapy
CollaRx Gentamicin is a Gentamicin-Collagen Sponge formulated and manufactured using Innocoll's proprietary CollaRx technology. Upon application to a wound the product releases the antibiotic gentamicin. According to Innocoll,
The study concluded that QR-443 was as effective in delaying the progression of cachexia when given orally as it had been shown to be when administered intra-peritoneally in
Eisai submitted the marketing authorization application for Inovelon in March 2005 to the European Medicines Agency. The drug has also received orphan status in the EU. Inovelon is
In the first agreement Evotec has been chosen as Solvay’s partner for fragment-based drug discovery. Solvay will access Evotec’s proprietary fragment-based screening platform and fragment library to identify
The expansion of AstraZeneca’s research facility will accommodate up to 100 additional researchers. They will join the more than 400 existing employees at the center. “Infectious disease is
Caraco’s Tramadol with acetaminophen is the generic equivalent of Ortho McNeil’s analgesic, Ultracet. The company commenced shipment of Tramadol with acetaminophen following the FDA’s approval to manufacture market
Under the proposed terms, Cell Therapeutics would issue the company’s shareholders 29,000,000 shares of Cell Therapeutics’ common stock, representing 19.9% of Cell Therapeutics’ outstanding shares of common stock.
Health Canada has issued a Notice of Compliance with conditions which confers marketing approval to the drug in Canada, while requiring the company to continue with a confirmatory
The investigational new drug application allows the commencement of a phase III multiple sclerosis (MS) trial in the US and has been granted on the basis of satisfying
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.